PAION AG

The European Medicines Agency has decided that Ipsen ’s Sohonos (palovarotene) should not be authorized for use in the EU, but it has recommended in favor of approval for Bristol Myers Squibb ’s Sot

Ofatumumab, Novartis ’s treatment for relapsing forms of multiple sclerosis (MS), is one of numerous new products that are this week up for an opinion by the European Medicines Agency on whether or n

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Backs Biond's IO Agent With Big

The European Medicines Agency has recommended that Enhertu and Retsevmo should be approved in the EU sooner than they normally would because the drugs, made by Daiichi Sankyo Co / AstraZeneca and E